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1. Introduction
   Cancer is the major cause of mortality and morbidity 
globally. According to recent estimates by the World Health 
Organization[1,2], annual cancer incidence in sub-Saharan 
Africa is 551 200 with a mortality of 421 000[3,4]. About 70% 
of all cancer deaths occurred in low- and middle-income 
countries[3,4]. 
   Molecular targeted agents are currently being studied in 
all treatment settings including that of chemoprevention, 
which is defined as the use of natural or synthetic non-
essential dietary agents to interrupt the process of 
carcinogenesis and to prevent or delay tumor growth[5,6]. 
The available treatment methods include surgery, 
chemotherapy, and radiation[7]. The current available 
methods of treatment all induce significant side effects 
and therefore the need for alternate adjuvant therapies 
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has arisen[8]. Natural products are extremely an important 
source of medicinal agents. Although there are some new 
approaches to drug discovery, such as combinatorial 
chemistry and computer based molecular modeling design, 
none of them can replace the importance of natural products 
in drug discovery and development[9,10]. Many synthetic 
drugs cause severe side effects that are not acceptable 
except as treatments of last resort for terminal diseases 
such as cancer and the metabolites discovered in medicinal 
plants may avoid the side effect of synthetic drugs[11].
   Antioxidants are a group of substances that are useful for 
fighting cancer and other processes that potentially lead 
to diseases such as atherosclerosis, Alzheimer, Parkinson, 
diabetes, and heart disease[11-13]. Antioxidants act by 
preventing the onset of cancer during carcinogenesis, and 
they are generally beneficial to cells. Oxidants damage 
macromolecules such as proteins, lipids, enzymes, and DNA 
and to combat these radicals, living organisms produce 
enzymes or rely on non-enzymatic molecules such as 
cysteine, ascorbic acid, flavonoids, and vitamin K for 
protection[12-14].
   Plant used in treating diseases is as old as civilization 
and traditional medicines are still a major part of habitual 
treatments of different maladies[7,15,16]. In recent times, 
folk medicine has taken an important place especially in 
developing countries where limited health services are 
available. The absence of scientific evaluation of medicinal 
plants to validate their use may cause serious adverse 
effects[7]. Annona muricata (A. muricata) is widely used in 
the traditional treatment of cancer in many countries. A. 
muricata commonly known as Graviola or soursop belongs 
to the family of Annonaceae and is the most tropical 
semi deciduous tree with the largest fruits of the Annona 
genus[17,18]. It is widely distributed and native to sub-
Saharan Africa countries. Earlier studies have demonstrated 
its anti-hyperglycemic, anti-hyperlipidemic, antimalarial, 
anti-parasitic, antibacterial, insecticidal, molluscicidal, 
antiviral and most importantly, their anticancer properties[19-
23].
   Ancient herbal medicines may have some advantages 
over single purified chemicals[24,25]. Often the different 
components in an herb have synergistic activities or buffer 
toxic effects. This study therefore aimed to determine the 
phytochemical composition, anti-oxidant activity as well as 
determine the in vitro anti-cancer potential of ethanolic and 
water leaves extracts of A. muricata from Eastern Uganda, as 
an alternative medicine in the prevention and treatment of 
cancer and other oxidative stress related diseases.
2. Materials and methods
2.1. Sample collection and authentication
   Fresh leaves of A. muricata L. were collected from the 
wild in Eastern Uganda in the districts of Kaliro and Iganga 
Municipality (Figure 1), during the month of August 2013. 
The plant (Figure 2) was identified and authenticated in the 
Makerere University Botanical Herbarium by Ms. Olivia 
Wanyana Mangeni. A voucher specimen was deposited in 
the herbarium under the collection number GY 021- 10/13- 
MB 300-0007/12-001.
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Figure 1. Map of Uganda showing the study areas of Kaliro and Iganga.
Figure 2. A. muricata leaves. 
2.2. Samples preparation and extraction
   The leaves of A. muricata were washed with water and cut 
into small pieces, drying was done at room temperature, and 
the dried leaves were powdered. Equal amounts (350 g) of 
powdered leaves were extracted using ethanol and distilled 
water for 3 d by the plant tissue homogenization method as 
previously described[26]. The extracts were then concentrated 
using rotary evaporator and dry block heater respectively 
and kept at -20 °C until used.
2.3. Chemicals, reagents and cell lines
   All chemicals and reagents were procured from certified 
suppliers and were of the highest analytical standard. The 
Ehrlich ascites carcinoma cells (EACC) had been obtained 
from the National Cancer Institute, Cairo, Egypt. The breast 
cancer cell lines MDA and SKBR3 were obtained from the 
Physiology and Cancer Biology Laboratory in the Zoology 
Department of the Faculty of Science at Cairo University.
2.4. Phytochemical screening of the extracts
   Phytochemical screening was done using standard 
procedures as previously described[26]. Samples of 
the ethanolic and water extracts of A. muricata were 
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screened for the following phyto constituents: alkaloids, 
saponins, terpenoids, flavonoids, coumarins and lactones, 
anthraquinones, tannins, cardiac glycosides, phenols and 
phytosterols.
2.5.  Determination of  re lat ive  abundance of  the 
phytochemicals
   Following the identification of the different phytochemicals 
present in both ethanolic and water leaves extracts of A. 
muricata, the relative abundance of the phytochemicals in 
each of the extracts was determined[27]. The results were 
analyzed using the Chi-square goodness of fit test between 
low and high abundance. For each of the nine runs per 
phytochemical, we allocated it as either high or low upon 
which the final allocation of the relative abundance would 
be based. Ho: The concentration of the phytochemical in the 
sample is neither high nor low, thus No preference (average); 
H1: There is a difference in the concentration of the 
phytochemical in the sample; α=0.1, Expected value (E)=4.5, 
Degrees of freedom=1 and χ2critical=2.7055. All conditions of 
the Chi-square test were met, except the standard minimum 
expected value of 5, for which our expected value was 4.5, as 
the total data set for each test was 9 values.
2.6. Determination of total phenolics
   The phenolic content of the A. muricata was determined[28]. 
Exactly 20 µL of the extract was taken from each of the 
extract and added to 1 580 µL of distilled water. This was 
followed by adding of 100 µL of Folin reagent (1%) and left 
to stand for 2 min. Then 300 µL of Na2CO3 (7.5%) was added 
to each of the samples, mixed thoroughly and left to stand 
for 2 h at 20 °C. All results were expressed as gallic using a 
standard curve of gallic acid and a linear equation was used 
to calculate the total phenols of the extracts.
2.7. Determination of reducing power 
   The reducing power of the ethanolic and water leaves 
extracts of A. muricata were determined[29]. Gallic acid 
was used as standard. A volume of 200 µL of each of the 
samples per extract as well as the standard at different 
concentrations were taken separately and mixed with 500 
µL of 0.2 mol/L phosphate buffer (pH 6.6) and 500 µL of 
potassium ferricyanide. The samples were then incubated at 
50 °C for 20 min. Then 500 µL of 10% trichloroacetic acid were 
added and centrifuged at 6 500 r/min for 16 min. About 700 µL 
of supernatant were added to 700 µL distilled water, 140 µL of 
freshly prepared ferric chloride, and left to stand for 10 min. 
Finally, the absorbance was measured at 700 nm. A standard 
curve for gallic acid was generated and the linear equation 
was used to calculate the reducing power of the extracts.
2.8. Quantification of antioxidant activity using the 1, 
1-diphenyl-2-picrylhydrazyl (DPPH) method 
   The free radical scavenging activity (RSA) was preceded. 
Different concentrations of the extracts (0, 250, 500, 750, 1 000, 
and 1 250 µg/mL) were used. A volume of 2.5 mL of 0.04% DPPH 
solution was mixed with 0.5 mL of all the concentrations 
of both extracts separately. After 30 min incubation at 
room temperature in the dark, the absorbance was read at 
517 nm in triplicates for each concentration[30]. Butylated 
hydroxytoluene (BHT) and butylated hydroxylanisole (BHA) 
were used as positive control. The percent inhibition of free 
radical formation was calculated as follows:
RSA (%)=[(Acontrol - Asample)/(Acontrol)]伊100
2.9. TLC fractionation of the ethanolic leaves extracts of A. 
muricata
   The ethanolic leaves extracts of A. muricata were 
fractionated using thin layer chromatography (TLC) 
technique. The extract was applied on silica gel 60 F254 TLC 
aluminum sheets (20伊20) (Merck, Darmstadt, Germany) at one 
of extremes to separate the different fractions. Mobile phase 
was petroleum ether: ethyl acetate: glacial acetic acid (4:1:1). 
Eleven fractions were scratched and named as EEAM1b-
EEAM11. All the fractions were tested for anti-oxidant 
activity, reducing power and anti-cancer activity.
2.10. In vitro anti-cancer activity of the extracts on EACC 
tumor cell-lines 
   The culture medium was prepared using RPMI1640 media 
(Gibco, Grand Island, USA), 10% inactivated fetal bovine 
serum (Gibco), and 100 units/mL penicillin and 100 mg/mL 
streptomycin were added. A line of Ehrlich ascites carcinoma 
has been used. About 2 mL of media containing EACC (2伊104 
cells) were transferred into a set of tubes each, then different 
concentrations of the extracts both water and ethanol (0, 250, 
500, 750, 1 000, and 1 250 µg/mL) were added. The tubes were 
incubated at 37 °C in the presence of 5% (v/v) CO2 for 2 h[31]. 
For each examined material (and control), a new clean, dry 
small test tube was used and 10 µL of cell suspension, 80 µL 
saline and 10 µL trypan blue (0.4%) were added and mixed. 
Then the number of living cells (non-stained) was calculated 
using a hemocytometer slide by microscope (Nikon, TMS). 
The extracts concentration providing 50% inhibition (IC50) was 
calculated from the graph plotting inhibition percentages 
against logarithm of concentration after transforming the 
concentrations. 
2.11. MTT assay for breast cancer cell lines MDA and SKBR3
   The culture medium was prepared using modified 
Earle’s salt with 1.2 g/L sodium carbonate and L-glutamine 
(Gibco, Grand Island, USA), 10% inactivated fetal bovine 
serum (Gibco), and 100 units/mL penicillin and 100 mg/
mL streptomycin were added. The anticancer effect of 
the ethanolic leaves extracts on the MDA and SKBR3 cell 
lines was determined by the MTT assay[32]. The cell count 
was adjusted to 1伊105 cells/0.1 mL and plated in 100 µL of 
medium/well in 96-well plates (Costar Corning, Rochester, 
NY). The cells were then incubated in the presence of 
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various concentrations of the ethanolic extract for 72 h at 37 
°C in triplicates per concentration (750, 500, 250, and 0 µg/
mL). The sample solutions were then removed and washed 
with phosphate buffer solution (pH 7.4). A volume of 20 µL/
well of 3-(4,5-dimethyl-2- thiazolyl)-2,5-diphenyl--
tetrazolium bromide (MTT 0.5%) was added. The samples were 
then incubated for 4 h. Amount of formazan was determined 
by measuring the absorbance at 570 nm using an ELISA plate 
reader (ELx800 universal micro plate reader, Biotech, USA). 
Concentration required for an inhibition concentration (IC50) 
was determined graphically. % Cell death was calculated 
using the following formula: 
% Cell death=(Control OD - Sample OD)/Control OD伊100
2.12. Cytotoxicity effect of ethanolic leaves extracts of A. 
muricata on normal spleen cells
   Spleen cells were isolated from normal healthy mice[33]. 
Spleen cells viability after and before incubation with 
different concentrations of ethanol at 37 °C in the presence 
of 5% (v/v) CO2 for 2 h was calculated using trypan blue 
technique[31]. All concentrations were assayed in triplicates.
2.13. Data analysis
   Quantitative and graphical data was analyzed using 
Microsoft Excel Package. The results of each series of 
experiments (performed in triplicates) were expressed as the 
mean依standard deviation. Qualitative data for phytochemical 
analysis was analyzed using the χ2 goodness of fit test. 
3. Results
3.1. Phytochemical analysis of ethanolic and water leaves 
extracts of A. muricata
   All phytochemicals tested were present in both types 
of A. muricata leaves extracts. The χ2 goodness of fit test 
has been used to allocate the relative abundance of each 
of the phytochemicals. Phytochemicals with computed χ2 
values (blue region) higher than the χ2critical (red area) were 
designated as high or low, depending on the initial count 
while those that had χ2 values less than the χ2critical were 
assigned average abundance as shown in Figures 3 and 4 
below.
Figure 3. Phytochemicals present in ethanolic leaves extracts of A. muricata 
with relative abundance computed from the χ2  test.
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Figure 4. Phytochemicals present in water leaf extracts of A. muricata  with 
relative abundance computed from the χ2 test.
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3.2. Total phenolic compounds (y=0.0026x+0.0044)
   Total phenolics in the water extract were computed to be 
(683.69依0.09) µg/mL gallic acid equivalents (GAE) while it 
was (372.92依0.15) µg/mL GAE in the ethanolic extract. These 
values indicate a higher level of phenolics in the water 
extract as compared to the ethanolic extracts. These results 
give an indication on the potential effect of the roles played 
by phenolic compounds in the activity of this plant with 
expectation of higher effect in water extracts as compared to 
ethanolic extracts. 
3.3. Reducing power of the extracts and fractions (y=0.0039x)
   The reducing power of both the ethanolic and water leaves 
extracts of A. muricata were determined by relation to that 
of the gallic acid from the standard curve with the linear 
equation y=0.0039x. The reducing power was 216.41 µg/mL 
in the water extract and 470.51 µg/mL GAE in the ethanolic 
extract. It was evident that the water extract had a higher 
reducing power than the ethanolic extract.
   Similarly, the reducing power of the TLC fractions of the 
ethanolic leaves extract was determined as above. The 
results expressed as µg/mL GAE were recorded as follows: 
EEAM1b (15.77), EEAM2 (1.54), EEAM3 (8.72), EEAM4 (37.69), 
EEAM5 (0.77), EEAM6 (3.33), EEAM7 (7.44), EEAM8 (5.77), EEAM9 
(9.36), EEAM10 (4.36) and EEAM11 (0.00). It was evident that the 
TLC fraction EEAM4 had the highest reducing power whereas 
fraction EEAM11 registered no reducing power activity. 
Although some fractions had a reducing power of more than 
15 µg/ml GAE, most of them registered a very low value of 
less than 10 µg/mL GAE. 
3.4. Quantification of antioxidant activity using the DPPH 
method
   Figure 5 shows a decrease in the concentration of 
DPPH radical due to the scavenging ability of the soluble 
constituents in the ethanolic and water leaves extracts of A. 
muricata. There was a direct positive relationship between 
antioxidant activity and increasing concentration of the 
extracts. The relationship was more pronounced in the water 
extract than in the ethanolic extract. There was ultimately 
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a higher antioxidant power registered by the water extracts 
as compared to the ethanolic extracts as represented by the 
calculated IC50 values of 0.9077 mg/mL and 2.0456 mg/mL 
respectively.
Figure 5. Antioxidant activity of leaves extracts of A. muricata on DPPH.
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   The antioxidant activities of each of the 11 fractions 
isolated from the ethanolic leaves extracts of A. muricata by 
TLC technique were also determined. The highest activity 
was recorded in fraction EEAM8 and the lowest activity 
was registered by fraction EEAM2. The percentage radical 
scavenging assay on DPPH of each of the fractions was as 
follows: negative control (0%), EEAM1b (3.95%), EEAM2 (1.09%), 
EEAM3 (1.91%), EEAM4 (7.28%), EEAM5 (30.34%), EEAM6 (9.52%), 
EEAM7 (5.2%), EEAM8 (31.16%), EEAM9 (28.98%), EEAM10 (29.52%) 
and EEAM11 (15.85%). The results showed relatively low 
antioxidant activity recorded by most of the fractions.
3.5. In vitro anti-cancer activity of leaves extracts of A. 
muricata
   Trypan blue-exclusion assay (TBEA) was used for the 
evaluation of anticancer activity of ethanolic and water 
leaves extracts of A. muricata against EACC, and for 
cytotoxicity against normal spleen cells. While the MTT 
assay was used for the evaluation of anticancer activity of 
ethanolic leaves extracts of A. muricata against two human 
breast cancer cell lines MDA and SKBR3. 
   Figure 6 shows the anticancer activity of ethanolic and 
water leaves extracts of A. muricata on EACC. The minimum 
detectable anticancer activity on EACC cell line was 
observed in the ethanolic leaves extract of A. muricata at a 
concentration of 250 µg/mL, with an inhibition of 32.9% cell 
death, and reaching a maximum inhibition of 100% cell death 
at a concentration of 750 µg/mL. IC50 of ethanolic extracts was 
determined to be 335.85 µg/mL. On the other hand, however, 
the water leaves extracts of A. muricata had no effect across 
all concentrations tested.
Figure 6. Effect of ethanolic and water leaves extracts of A. muricata on 
EACC.
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   Figure 7 shows the anticancer activity of ethanolic leaves 
extracts of A. muricata on MDA cell line while Figure 8 
shows the anticancer activity of ethanolic leaves extracts of 
A. muricata on SKBR3 cell line. There is a general increase 
in percentage cell death with increase in concentration of 
the ethanolic extracts. The effect of ethanolic extract on two 
human breast cancer cell lines MDA and SKBR3 was tested at 
concentrations ranging from 250 to 750 µg/mL for 72 h, and 
% of cell death was measured by the MTT assay. The results 
demonstrated a strong dose-dependent inhibition in treated 
cell lines. The ethanolic leaves extracts were thus found to 
be highly cytotoxic in vitro against the two human breast 
cancer cell lines MDA and SKBR3 (Figures 7 and 8) with IC50 of 
248.77 µg/mL and 202.33 µg/mL respectively.
Figure 7. Effect of ethanolic leaves extracts of A. muricata on MDA cell line.
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Figure 8. Effect of ethanolic leaves extracts of A. muricata on SKBR3 cell 
line.
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   Figure 9 below shows results for the cytotoxicity test for the 
activity of ethanolic leaves extracts of A. muricata on normal 
spleen cells using the TBEA. There was no cytotoxicity effect 
registered across the whole range of concentrations used, 
implying that the extracts had no effect on the normal cells, 
and an indication of the high selectivity for the target cell 
lines.
Figure 9. Effect of ethanolic leaves extracts of A. muricata on normal spleen 
cells.
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   The anticancer activity of the ethanolic leaves extract TLC 
fractions of A. muricata was determined. Three fractions 
EEAM1b, EEAM2, and EEAM4 showed no activity. The 
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remaining fractions had some anticancer activities and four 
fractions showed more than 50% cell death. The percentage 
cell death registered by the different fractions were as 
follows: negative control (0%), EEAM1b (0%), EEAM2 (0%), 
EEAM3 (8.5%), EEAM4 (0%), EEAM5 (10%), EEAM6 (40.2%), EEAM7 
(5%), EEAM8 (53.75%), EEAM9 (76%), EEAM10 (84.5%) and EEAM11 
(64%). The results showed that the net effect of the extracts 
would be contributed upon by only a few of the fractions 
in the extract as revealed above. This contribution would 
be either synergistic or inhibitory affecting the final effect 
registered by the entire extract as a whole.
   Figure 10 below shows a comparison between antioxidant 
activity (reducing power and %RSA) and cytotoxic activity 
(% cell death) of ethanolic leaves extracts TLC fractions of 
A. muricata. It revealed a general trend in the relationship 
between the two aspects of the study where all fractions 
which showed high anticancer activity had high antioxidant 
activity (as measured by the reducing power and DPPH 
radical scavenging assay), while the opposite trend was not. 
Figure 10. Comparison between antioxidant and anticancer activity of 
ethanolic leaves extracts TLC fractions of A. muricata.
A: Negative control; B: EEAM1b; C: EEAM2; D: EEAM3; E: EEAM4; F: EEAM5; 
G: EEAM6; H: EEAM7; I: EEAM8; J: EEAM9; K: EEAM10; L: EEAM11.
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4. Discussion
   Phytochemical screening conducted on leaves extracts of 
A. muricata revealed the presence of following classes of 
compounds: alkaloids, flavonoids, terpenoids, coumarins 
and lactones, anthraquinones, tannins, cardiac glycosides, 
phenols, phytosterols, and saponins. They were present 
in both the ethanolic and water leaves extracts, but with 
noticeable differences in relative abundance ranging from 
low, average and high. These results are in line with earlier 
studies that carried out on the ethanolic seeds extract of A. 
muricata, and the phytochemical tests showed that ethanol 
soursop seeds extract contained secondary metabolites 
compounds: saponins, alkaloids and triterpenoids, 
flavonoids, anthraquinones, tannins, and cardiac glycosides. 
They are defense chemical compounds of plants produced in 
the plant tissue[17,34]. 
   The extracts were found to be rich in alkaloids which 
have wide pharmacological effects and thus have been 
used extensively as drugs in medical field. The detection 
of high levels of alkaloids in the leaves extracts of A. 
muricata further reinforces the presence of alkaloid in this 
species as already outlined by other independent studies 
that showed that among the chemical constituents found 
in A. muricata, the alkaloids and essential oils stood out[8]. 
Cardiac glycosides are molecules used in treatment of heart 
failure[35], hence the present findings are suitable for use in 
treatment of heart diseases.
   Generally, presence of alkaloids, flavonoids, terpenoids, 
coumarins and lactones, anthraquinones, tannins, cardiac 
glycosides, phenols, phytosterols, and saponins confirms 
that A. muricata leaves extracts contain molecules known 
for extensive use in the medical field both traditionally 
and pharmaceutically. This would be an indication for 
its potential use in anti-inflammatory, anti-allergic, 
antibacterial, and antiviral, heart failure, antioxidant and 
anticancer activity among others. These findings emphasize 
the value of traditional knowledge in the use of plants for 
medicinal use as well as pharmaceutical development. The 
use of A. muricata in traditional medicine is validated by 
presence of these phytochemicals of known health benefits 
and thus further studies on this species are needed.
   The phenolic content of the A. muricata was determined 
and all results were expressed as GAE. Typical phenolics 
that possess antioxidant activity have been characterized as 
phenolic acids and flavonoids[36,37]. Phenols are among the 
non-enzymatic compounds obtained from natural sources, 
which have received high attention due to their proven 
antioxidant capabilities. Although phenolic compounds 
have been related to antioxidant activity, some studies 
have emphasized specific classes such as flavonoids and 
tannins[12]. Our results revealed that the water leaves 
extract had higher total phenolic content as compared to the 
ethanolic leaves extract of A. muricata. The higher phenolic 
content in the water extract would partly contribute to its 
higher antioxidant activity.
   Several methods have been developed to measure the 
efficiency of antioxidants as pure compounds or in extract. 
These methods focus on different mechanisms of the oxidant 
defense system that is scavenging active oxygen species and 
hydroxyle radicals, inhibiting lipid peroxidation, or chelating 
metal ions[29]. The reducing capacity of a compound may 
serve as a significant indicator of its potential antioxidant 
activity. It was found that in general, the reducing power 
of the water leaves extracts was higher than that of the 
ethanolic leaves extracts, giving an indication in the 
potential higher antioxidant activity of the extracts. 
   The 11 fractions had a very low reducing power of less 
than 50 µg/mL GAE each. This may be translated into the 
observation that perhaps the final reducing power of the 
extract is as a result of the combined effect of each of the 
compounds in the fractions.
   Free RSA of the leaves extracts was determined. The 
data showed that water leaves extracts of A. muricata had 
a higher free radical inhibition with an IC50 of 0.9077 mg/
mL as compared to the ethanolic leaves extract with an IC50 
of 2.0456 mg/mL. The standard antioxidants BHA and BHT 
were used as positive controls. This free RSA of the leaves 
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extracts was far lower than the standard positive controls, 
implying that the extracts, at similar concentrations may not 
be competitively strong antioxidants. It is however likely 
that the leaves extract’s antioxidant activity of A. muricata 
may be as strong as standard BHA and BHT, given that the 
samples assayed in this study were crude extracts, while the 
standard controls are usually very purified compounds. 
   It is not surprising that the water leaves extracts of A. 
muricata had a stronger antioxidant activity as compared 
to the ethanolic leaves extract. This revealed that the total 
phenolics were two fold higher in the water leaves extracts 
than the ethanolic leaves extracts, and phenolics had long 
been associated with antioxidant activity. Similarly, the 
water leaves extracts had reducing power almost two times 
higher than that of the ethanolic leaves extracts. In general 
however, the relatively strong antioxidant activity makes this 
plant efficient in managing oxidative stress related diseases; 
this could be the reason why it is used in traditional 
medicine to manage such diseases where the water extracts 
are mostly applied. 
   Earlier studies revealed the antioxidant activity of 
methanolic bark extract of A. muricata with an IC50 of 
(0.22150依0.01652) mg/mL, which is far higher than our current 
study[12]. Also in another study, the ethanolic bark extracts 
of A. muricata registered the IC50 values as 0.109 mg/mL[38]. 
The difference in antioxidant power in results recorded 
can be partly attributed to the fact that different parts of 
the plant were used in the current study and the previous 
studies attributed to the difference in geographical locations, 
as both studies were conducted in different areas. The 
results however agree with Mishra et al. who noted that A. 
muricata leaves extracts had antioxidant and molluscicidal 
properties[8].
   The ethanolic extract fractions showed relatively low 
reducing power less than 50% inhibition even in the fraction 
showing the highest activity. This suggests that probably the 
overall antioxidant activity of the extract is as a result of the 
synergistic combination of the activity of all the compounds 
in the fractions, especially fractions EEAM5, EEAM8, EEAM9, 
EEAM10, and EEAM11, which registered activity of higher 
than 15%. These results provide a possible lead towards the 
further studies and development of pharmaceutical products 
with antioxidant properties by targeting the fractions 
showing the highest activity.
   The results for anticancer activity studies showed that the 
ethanolic leaves extract had a very high anticancer activity 
on three cell lines of EACC, MDA and SKBR3 with IC50 values 
which are low and very close to each other, despite the 
difference in the method used and source of the cells. 
   An integrated part of cancer cell development is the 
resistance to programmed cell death (apoptosis) and 
therefore re-establishment of apoptosis in cancer cells is 
a target mechanism for anticancer agents[39]. Some plant-
derived products are known to selectively induce apoptosis 
in cancer cells, which represent the ideal property for 
successful anticancer agents[7,39]. The current study showed 
the highly effective action of the ethanolic leaves extract 
of A. muricata and can be used in the management and 
treatment of cancer. This is in line with a study which 
showed that any extract had anticancer and cytotoxic activity 
if it had an IC50 value less than 1 000 µg/mL after 24 h contact 
time, and that the smaller the IC50 value of a test compound, 
the more toxic the compound was[40].
   The results of the cytotoxicity test on normal spleen cells 
of the ethanolic leaves extracts of A. muricata indicated a 
very high selectivity of the extracts for cancer cells, as they 
showed no effect on the normal spleen cells throughout the 
range of concentrations tested. 100% spleen cell viability was 
observed at all tested concentrations. The high selectivity 
of the extract for cancer cells is a very important aspect for 
its use in treatment of cancer as normal cells would not be 
targeted.
   The current study confirms earlier studies which 
showed that extracts of A. muricata had been reported 
to be selectively toxic in vitro to certain types of tumour 
cells including: lung carcinoma cell lines, human breast 
solid tumour lines, prostate adenocarcinoma, pancreatic 
carcinoma cell lines, colon adenocarcinoma cell lines, 
mammary adenocarcinoma cell lines, liver cancer cell 
lines, human lymphoma cell lines and multi-drug resistant 
human breast adenocarcinoma[20]. Other earlier studies also 
demonstrated it to be selectively toxic against various types 
of the cancerous cells without harming healthy cells[23,41,42].
   The water extracts however showed no effect throughout 
the range of tested concentrations. This conspicuous lack 
of anticancer activity of the water leaves extract despite 
its having a high antioxidant activity and reducing power 
compared to the ethanolic extract may elicit a number 
of theories pertaining the mechanism of action of the 
anticancer agents in this plant which may be different from 
the commonly generalized idea that anticancer activity is 
directly related to antioxidant activity. Our results are in 
line with earlier preliminary studies which showed a good 
relationship between antioxidant efficacy of plant extracts 
and anticancer potency. All of the extracts which gave high 
anticancer potency have high antioxidant activity while the 
opposite trend is not[13].
   In this case, we propose that the anticancer agents present 
in the ethanolic leaves extracts may be acting in a very 
different mechanism from that of the antioxidant mechanism. 
These compounds related to the anticancer activity may 
also be absent from the water extract and not easily 
detected by the common phytochemical screening methods. 
Earlier studies showed that A. muricata contained many 
active compounds and chemicals which were the natural 
phytochemicals known as annonaceous acetogenins[22,43], yet 
there are no readily available methods for identifying them. 
Some of these may have been present in very high quantities 
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in the ethanolic extract, yet absent in the water extract, 
leading to the difference in anticancer activity. However, 
more studies need to be conducted to elucidate the root 
cause of this difference.
   The anticancer activity of the ethanolic leaves extracts 
fractions showed the highest single activity to be caused by 
the EEAM10 fraction at a cytotoxic level of more than 80% cell 
death. Generally, four fractions showed very good promising 
anticancer activity with cytotoxicity levels of more than 
50% cell death, and these fractions were EEAM8, EEAM9, 
EEAM10 and EEAM11. These fractions may be responsible for 
the highest anticancer activity of ethanolic extract. These 
compounds may be not present in water extract, specifying 
that the fractions were in medium in polarity (nature of 
mobile phase). The encouraging results obtained from this 
work on anticancer activity of ethanolic leaves extracts of A. 
muricata and isolation of the most active fractions represent 
an important step towards the effective purification, 
characterization of the active principles in this extract 
and to understand the mechanism of cytotoxicity of these 
extracts. This study showed A. muricata was a promising 
new antioxidant and anticancer agent.
   The in vitro antioxidant activity of ethanolic and water 
leaves extracts of A. muricata revealed a significant 
antioxidant activity in water extract and thus its potential 
use in oxidative stress related diseases management. Our 
study has also proved that ethanolic leaves extracts of A. 
muricata have a direct potential inhibitory action on three 
cell lines (EACC, MDA and SKBR3).  
   Hence, it is anticipated that A. muricata would be a useful 
pharmaceutical material to treat breast cancer. Four TLC 
fractions have anticancer activity more than 50%. There 
is also hope that this plant would be equally cytotoxic on 
other types of cancers, however, further studies have to be 
extended for other cell lines and the molecular levels are 
required to identify specific mechanism that could induce 
growth inhibition. Our results also suggest that inclusion of 
antioxidant and anticancer -rich extract or fractions of A. 
muricata as a dietary supplementary has beneficial effects 
for human health. The data of the current work appear 
useful for further research aiming to chemically identify 
the specific compounds responsible for the antioxidant and 
anticancer activities of A. muricata.
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